By Wendy Van Sickle
Columbus, Ohio, June 7 – Citigroup Global Markets Holdings Inc. priced $3.47 million of autocallable contingent coupon equity-linked securities due June 8, 2021 tied to the common stocks of Bristol-Myers Squibb Co. and Johnson & Johnson, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
The notes will pay a contingent quarterly coupon at an annual rate of 8% if each stock closes at or above its 65% coupon barrier price on the review date for that quarter.
The notes will be automatically redeemed at par plus interest if each stock closes at or above its initial price on any potential redemption date beginning in November.
If the notes are not called and the final price of each stock is at least 65% of its initial price, the payout at maturity will be par. Otherwise, investors will be fully exposed to the decline of the lesser-performing stock.
Citigroup Global Markets Inc. is the underwriter.
Issuer: | Citigroup Global Markets Holdings Inc.
|
Guarantor: | Citigroup Inc.
|
Issue: | Autocallable contingent coupon equity-linked securities
|
Underlying stocks: | Bristol-Myers Squibb Co. and Johnson & Johnson
|
Amount: | $3,473,000
|
Maturity: | June 8, 2021
|
Coupon: | 8% annualized, payable quarterly if each stock closes at or above coupon barrier price on review date for that quarter
|
Price: | Par
|
Payout at maturity: | Par if each stock’s final price is at least 65% of initial price; otherwise, full exposure to decline of lesser-performing stock
|
Call: | At par plus interest if each stock closes at or above initial price on any potential redemption date beginning in November
|
Initial prices: | $52.27 for Bristol-Myers, $119.40 for Johnson & Johnson
|
Coupon barriers/final barriers: | $33.976 for Bristol-Myers, $77.61 for Johnson & Johnson; 65% of initial prices
|
Pricing date: | May 29
|
Settlement date: | May 31
|
Agent: | Citigroup Global Markets Inc.
|
Fees: | 2.5%
|
Cusip: | 17324CUV6
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.